Burling Wealth Partners LLC Takes Position in Danaher Co. (NYSE:DHR)

Burling Wealth Partners LLC bought a new position in shares of Danaher Co. (NYSE:DHR) during the fourth quarter, Holdings Channel reports. The fund bought 25,377 shares of the conglomerate’s stock, valued at approximately $5,825,000. Danaher comprises 1.2% of Burling Wealth Partners LLC’s portfolio, making the stock its 25th largest position.

Other institutional investors and hedge funds have also bought and sold shares of the company. Gilbert & Cook Inc. lifted its position in Danaher by 2.5% in the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after buying an additional 42 shares during the last quarter. Grimes & Company Inc. raised its stake in shares of Danaher by 0.6% during the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after acquiring an additional 43 shares in the last quarter. Dakota Community Bank & Trust NA boosted its stake in shares of Danaher by 16.4% in the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after purchasing an additional 45 shares in the last quarter. Howard Capital Management Group LLC grew its holdings in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 48 shares during the last quarter. Finally, Spinnaker Trust raised its position in Danaher by 1.2% in the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after purchasing an additional 50 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Up 2.3 %

Shares of NYSE DHR opened at $196.52 on Thursday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a 50-day moving average of $201.21 and a 200 day moving average of $225.57. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The stock has a market cap of $140.45 billion, a P/E ratio of 37.22, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Friday, March 28th. Danaher’s payout ratio is presently 24.85%.

Analyst Ratings Changes

DHR has been the topic of a number of recent research reports. UBS Group reduced their price objective on Danaher from $275.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday. Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research note on Friday, March 14th. The Goldman Sachs Group dropped their price objective on Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a research note on Wednesday. Citigroup reaffirmed a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Finally, Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $264.40.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.